Navy Partners with Ichor Medical Systems, Inc. to Develop a Vaccine for Anthrax and Plague

SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced electroporation system is being used worldwide to increase the effectiveness of DNA drug and vaccine delivery, has been awarded a two-year contract valued at over $2.3 million by the Defense Threat Reduction Agency (DTRA). Ichor will assist the Biological Defense Research Directorate (BDRD) of the Naval Medical Research Center (NMRC) in Rockville, Maryland in the development of a DNA vaccine for anthrax and plague.

MORE ON THIS TOPIC